Structure Therapeutics (GPCR) Non-Current Assets (2022 - 2026)

Structure Therapeutics' Non-Current Assets history runs 5 years deep, the most recent figure standing at $17.5 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 3.54% year-over-year to $17.5 million in Q1 2026; TTM through Mar 2026 was $66.4 million, a 38.32% increase from a year earlier, with the FY2025 full-year figure at $13.6 million, up 12.34% from the prior year.
• Non-Current Assets rose to $17.5 million in Q1 2026 per GPCR's latest filing, from $13.6 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $18.1 million in Q3 2025 and bottomed at $1.2 million in Q1 2023.
• The 5-year median for Non-Current Assets is $9.5 million (2024), against an average of $10.3 million.
• Across the five-year window, Non-Current Assets surged 680.1% in 2024 and climbed 3.54% in 2026, its largest moves.
• Year by year, Non-Current Assets stood at $4.8 million in 2022, then surged by 76.81% to $8.4 million in 2023, then surged by 44.12% to $12.1 million in 2024, then grew by 12.34% to $13.6 million in 2025, then gained by 28.73% to $17.5 million in 2026.
• Per Business Quant, the three latest GPCR Non-Current Assets figures stand at $17.5 million (Q1 2026), $13.6 million (Q4 2025), and $18.1 million (Q3 2025).